Download Zipped Amended WordPerfect HB0254S01.ZIP
[Introduced][Status][Bill Documents][Fiscal Note][Bills Directory]

First Substitute H.B. 254

This document includes Senate 2nd Reading Floor Amendments incorporated into the bill on Thu, Mar 1, 2012 at 10:53 AM by khelgesen. -->

Representative Gage Froerer proposes the following substitute bill:


             1     
CONTROLLED SUBSTANCES AMENDMENTS

             2     
2012 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Chief Sponsor: Gage Froerer

             5     
Senate Sponsor: Allen M. Christensen

             6     
             7      LONG TITLE
             8      General Description:
             9          This bill modifies the Utah Controlled Substances Act.
             10      Highlighted Provisions:
             11          This bill:
             12          .    amends the definition of a controlled substance analog to allow proof that the
             13      substance is chemically substantially similar to a controlled substance, without
             14      requiring proof of the effect of the substance by the expert testimony of a
             15      pharmacologist;
             16          .    adds benzylpiperazine to Schedule I of the controlled substances list; and
             17          .    adds AM-2201, RCS-4, JWH-210, and JWH-203 to the list of listed controlled
             18      substances.
             19      Money Appropriated in this Bill:
             20          None
             21      Other Special Clauses:
             22          None
             23      Utah Code Sections Affected:
             24      AMENDS:
             25          58-37-2, as last amended by Laws of Utah 2011, Chapter 12


             26          58-37-4, as last amended by Laws of Utah 2011, Chapter 12
             27          58-37-4.2, as enacted by Laws of Utah 2011, Chapter 12
             28     
             29      Be it enacted by the Legislature of the state of Utah:
             30          Section 1. Section 58-37-2 is amended to read:
             31           58-37-2. Definitions.
             32          (1) As used in this chapter:
             33          (a) "Administer" means the direct application of a controlled substance, whether by
             34      injection, inhalation, ingestion, or any other means, to the body of a patient or research subject
             35      by:
             36          (i) a practitioner or, in the practitioner's presence, by the practitioner's authorized agent;
             37      or
             38          (ii) the patient or research subject at the direction and in the presence of the
             39      practitioner.
             40          (b) "Agent" means an authorized person who acts on behalf of or at the direction of a
             41      manufacturer, distributor, or practitioner but does not include a motor carrier, public
             42      warehouseman, or employee of any of them.
             43          (c) "Consumption" means ingesting or having any measurable amount of a controlled
             44      substance in a person's body, but this Subsection (1)(c) does not include the metabolite of a
             45      controlled substance.
             46          (d) "Continuing criminal enterprise" means any individual, sole proprietorship,
             47      partnership, corporation, business trust, association, or other legal entity, and any union or
             48      groups of individuals associated in fact although not a legal entity, and includes illicit as well
             49      as licit entities created or maintained for the purpose of engaging in conduct which constitutes
             50      the commission of episodes of activity made unlawful by Title 58, Chapter 37, Utah Controlled
             51      Substances Act, Chapter 37a, Utah Drug Paraphernalia Act, Chapter 37b, Imitation Controlled
             52      Substances Act, Chapter 37c, Utah Controlled Substance Precursor Act, or Chapter 37d,
             53      Clandestine Drug Lab Act, which episodes are not isolated, but have the same or similar
             54      purposes, results, participants, victims, methods of commission, or otherwise are interrelated
             55      by distinguishing characteristics. Taken together, the episodes shall demonstrate continuing
             56      unlawful conduct and be related either to each other or to the enterprise.


             57          (e) "Control" means to add, remove, or change the placement of a drug, substance, or
             58      immediate precursor under Section 58-37-3 .
             59          (f) (i) "Controlled substance" means a drug or substance:
             60          (A) included in Schedules I, II, III, IV, or V of Section 58-37-4 ;
             61          (B) included in Schedules I, II, III, IV, or V of the federal Controlled Substances Act,
             62      Title II, P.L. 91-513;
             63          (C) that is a controlled substance analog; or
             64          (D) listed in Section 58-37-4.2 .
             65          (ii) "Controlled substance" does not include:
             66          (A) distilled spirits, wine, or malt beverages, as those terms are defined in Title 32B,
             67      Alcoholic Beverage Control Act;
             68          (B) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
             69      prevention of disease in human or other animals, which contains ephedrine, pseudoephedrine,
             70      norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
             71      transferred, or furnished as an over-the-counter medication without prescription; or
             72          (C) dietary supplements, vitamins, minerals, herbs, or other similar substances
             73      including concentrates or extracts, which:
             74          (I) are not otherwise regulated by law; and
             75          (II) may contain naturally occurring amounts of chemical or substances listed in this
             76      chapter, or in rules adopted pursuant to Title 63G, Chapter 3, Utah Administrative Rulemaking
             77      Act.
             78          (g) (i) "Controlled substance analog" means:
             79          (A) a substance the chemical structure of which is substantially similar to the chemical
             80      structure of a controlled substance listed in Schedules I and II of Section 58-37-4 , a substance
             81      listed in Section 58-37-4.2 , or in Schedules I and II of the federal Controlled Substances Act,
             82      Title II, P.L. 91-513 S. [ : ] ; .S
             83          [(A)] (B) S. a substance .S which has a stimulant, depressant, or hallucinogenic effect
             83a      on the central
             84      nervous system substantially similar to the stimulant, depressant, or hallucinogenic effect on
             85      the central nervous system of controlled substances [in the schedules set forth in Subsection
             86      (1)(f), or a substance listed in Section 58-37-4.2 ; or] listed in Schedules I and II of Section
             87      58-37-4 , substances listed in Section 58-37-4.2 , or substances listed in Schedules I and II of the


             88      federal controlled substances Act, Title II, P.L. 91-513; or
             89          [(B)] (C) A substance which, with respect to a particular individual, is represented or
             90      intended to have a stimulant, depressant, or hallucinogenic effect on the central nervous system
             91      substantially similar to the stimulant, depressant, or hallucinogenic effect on the central
             92      nervous system of controlled substances [in the schedules or list set forth in this Subsection
             93      (1)] listed in Schedules I and II of Section 58-37-4, substances listed in Section 58-37-4.2, or
             94      substances listed in Schedules I and II of the federal controlled substances Act, Title II, P.L.
             95      91-513.
             96          (ii) "Controlled substance analog" does not include:
             97          (A) a controlled substance currently scheduled in Schedules I through V of Section
             98      58-37-4 ;
             99          (B) a substance for which there is an approved new drug application;
             100          (C) a substance with respect to which an exemption is in effect for investigational use
             101      by a particular person under Section 505 of the Food, Drug, and Cosmetic Act, 21 U.S.C. 355,
             102      to the extent the conduct with respect to the substance is permitted by the exemption;
             103          (D) any substance to the extent not intended for human consumption before an
             104      exemption takes effect with respect to the substance;
             105          (E) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
             106      prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
             107      norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
             108      transferred, or furnished as an over-the-counter medication without prescription; or
             109          (F) dietary supplements, vitamins, minerals, herbs, or other similar substances
             110      including concentrates or extracts, which are not otherwise regulated by law, which may
             111      contain naturally occurring amounts of chemical or substances listed in this chapter, or in rules
             112      adopted pursuant to Title 63G, Chapter 3, Utah Administrative Rulemaking Act.
             113          (h) "Conviction" means a determination of guilt by verdict, whether jury or bench, or
             114      plea, whether guilty or no contest, for any offense proscribed by Title 58, Chapters 37, 37a,
             115      37b, 37c, or 37d, or for any offense under the laws of the United States and any other state
             116      which, if committed in this state, would be an offense under Title 58, Chapters 37, 37a, 37b,
             117      37c, or 37d.
             118          (i) "Counterfeit substance" means:


             119          (i) any controlled substance or container or labeling of any controlled substance that:
             120          (A) without authorization bears the trademark, trade name, or other identifying mark,
             121      imprint, number, device, or any likeness of them, of a manufacturer, distributor, or dispenser
             122      other than the person or persons who in fact manufactured, distributed, or dispensed the
             123      substance which falsely purports to be a controlled substance distributed by any other
             124      manufacturer, distributor, or dispenser; and
             125          (B) a reasonable person would believe to be a controlled substance distributed by an
             126      authorized manufacturer, distributor, or dispenser based on the appearance of the substance as
             127      described under Subsection (1)(i)(i)(A) or the appearance of the container of that controlled
             128      substance; or
             129          (ii) any substance other than under Subsection (1)(i)(i) that:
             130          (A) is falsely represented to be any legally or illegally manufactured controlled
             131      substance; and
             132          (B) a reasonable person would believe to be a legal or illegal controlled substance.
             133          (j) "Deliver" or "delivery" means the actual, constructive, or attempted transfer of a
             134      controlled substance or a listed chemical, whether or not an agency relationship exists.
             135          (k) "Department" means the Department of Commerce.
             136          (l) "Depressant or stimulant substance" means:
             137          (i) a drug which contains any quantity of barbituric acid or any of the salts of barbituric
             138      acid;
             139          (ii) a drug which contains any quantity of:
             140          (A) amphetamine or any of its optical isomers;
             141          (B) any salt of amphetamine or any salt of an optical isomer of amphetamine; or
             142          (C) any substance which the Secretary of Health and Human Services or the Attorney
             143      General of the United States after investigation has found and by regulation designated
             144      habit-forming because of its stimulant effect on the central nervous system;
             145          (iii) lysergic acid diethylamide; or
             146          (iv) any drug which contains any quantity of a substance which the Secretary of Health
             147      and Human Services or the Attorney General of the United States after investigation has found
             148      to have, and by regulation designated as having, a potential for abuse because of its depressant
             149      or stimulant effect on the central nervous system or its hallucinogenic effect.


             150          (m) "Dispense" means the delivery of a controlled substance by a pharmacist to an
             151      ultimate user pursuant to the lawful order or prescription of a practitioner, and includes
             152      distributing to, leaving with, giving away, or disposing of that substance as well as the
             153      packaging, labeling, or compounding necessary to prepare the substance for delivery.
             154          (n) "Dispenser" means a pharmacist who dispenses a controlled substance.
             155          (o) "Distribute" means to deliver other than by administering or dispensing a controlled
             156      substance or a listed chemical.
             157          (p) "Distributor" means a person who distributes controlled substances.
             158          (q) "Division" means the Division of Occupational and Professional Licensing created
             159      in Section 58-1-103 .
             160          (r) (i) "Drug" means:
             161          (A) a substance recognized in the official United States Pharmacopoeia, Official
             162      Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or any
             163      supplement to any of them, intended for use in the diagnosis, cure, mitigation, treatment, or
             164      prevention of disease in humans or animals;
             165          (B) a substance that is required by any applicable federal or state law or rule to be
             166      dispensed by prescription only or is restricted to administration by practitioners only;
             167          (C) a substance other than food intended to affect the structure or any function of the
             168      body of humans or other animals; and
             169          (D) substances intended for use as a component of any substance specified in
             170      Subsections (1)(r)(i)(A), (B), and (C).
             171          (ii) "Drug" does not include dietary supplements.
             172          (s) "Drug dependent person" means any individual who unlawfully and habitually uses
             173      any controlled substance to endanger the public morals, health, safety, or welfare, or who is so
             174      dependent upon the use of controlled substances as to have lost the power of self-control with
             175      reference to the individual's dependency.
             176          (t) "Food" means:
             177          (i) any nutrient or substance of plant, mineral, or animal origin other than a drug as
             178      specified in this chapter, and normally ingested by human beings; and
             179          (ii) foods for special dietary uses as exist by reason of a physical, physiological,
             180      pathological, or other condition including but not limited to the conditions of disease,


             181      convalescence, pregnancy, lactation, allergy, hypersensitivity to food, underweight, and
             182      overweight; uses for supplying a particular dietary need which exist by reason of age including
             183      but not limited to the ages of infancy and childbirth, and also uses for supplementing and for
             184      fortifying the ordinary or unusual diet with any vitamin, mineral, or other dietary property for
             185      use of a food. Any particular use of a food is a special dietary use regardless of the nutritional
             186      purposes.
             187          (u) "Immediate precursor" means a substance which the Attorney General of the United
             188      States has found to be, and by regulation designated as being, the principal compound used or
             189      produced primarily for use in the manufacture of a controlled substance, or which is an
             190      immediate chemical intermediary used or likely to be used in the manufacture of a controlled
             191      substance, the control of which is necessary to prevent, curtail, or limit the manufacture of the
             192      controlled substance.
             193          (v) "Indian" means a member of an Indian tribe.
             194          (w) "Indian religion" means any religion:
             195          (i) the origin and interpretation of which is from within a traditional Indian culture or
             196      community; and
             197          (ii) which is practiced by Indians.
             198          (x) "Indian tribe" means any tribe, band, nation, pueblo, or other organized group or
             199      community of Indians, including any Alaska Native village, which is legally recognized as
             200      eligible for and is consistent with the special programs, services, and entitlements provided by
             201      the United States to Indians because of their status as Indians.
             202          (y) "Manufacture" means the production, preparation, propagation, compounding, or
             203      processing of a controlled substance, either directly or indirectly by extraction from substances
             204      of natural origin, or independently by means of chemical synthesis or by a combination of
             205      extraction and chemical synthesis.
             206          (z) "Manufacturer" includes any person who packages, repackages, or labels any
             207      container of any controlled substance, except pharmacists who dispense or compound
             208      prescription orders for delivery to the ultimate consumer.
             209          (aa) "Marijuana" means all species of the genus cannabis and all parts of the genus,
             210      whether growing or not; the seeds of it; the resin extracted from any part of the plant; and every
             211      compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or


             212      resin. The term does not include the mature stalks of the plant, fiber produced from the stalks,
             213      oil or cake made from the seeds of the plant, any other compound, manufacture, salt,
             214      derivative, mixture, or preparation of the mature stalks, except the resin extracted from them,
             215      fiber, oil or cake, or the sterilized seed of the plant which is incapable of germination. Any
             216      synthetic equivalents of the substances contained in the plant cannabis sativa or any other
             217      species of the genus cannabis which are chemically indistinguishable and pharmacologically
             218      active are also included.
             219          (bb) "Money" means officially issued coin and currency of the United States or any
             220      foreign country.
             221          (cc) "Narcotic drug" means any of the following, whether produced directly or
             222      indirectly by extraction from substances of vegetable origin, or independently by means of
             223      chemical synthesis, or by a combination of extraction and chemical synthesis:
             224          (i) opium, coca leaves, and opiates;
             225          (ii) a compound, manufacture, salt, derivative, or preparation of opium, coca leaves, or
             226      opiates;
             227          (iii) opium poppy and poppy straw; or
             228          (iv) a substance, and any compound, manufacture, salt, derivative, or preparation of the
             229      substance, which is chemically identical with any of the substances referred to in Subsection
             230      (1)(cc)(i), (ii), or (iii), except narcotic drug does not include decocainized coca leaves or
             231      extracts of coca leaves which do not contain cocaine or ecgonine.
             232          (dd) "Negotiable instrument" means documents, containing an unconditional promise
             233      to pay a sum of money, which are legally transferable to another party by endorsement or
             234      delivery.
             235          (ee) "Opiate" means any drug or other substance having an addiction-forming or
             236      addiction-sustaining liability similar to morphine or being capable of conversion into a drug
             237      having addiction-forming or addiction-sustaining liability.
             238          (ff) "Opium poppy" means the plant of the species papaver somniferum L., except the
             239      seeds of the plant.
             240          (gg) "Person" means any corporation, association, partnership, trust, other institution or
             241      entity or one or more individuals.
             242          (hh) "Poppy straw" means all parts, except the seeds, of the opium poppy, after


             243      mowing.
             244          (ii) "Possession" or "use" means the joint or individual ownership, control, occupancy,
             245      holding, retaining, belonging, maintaining, or the application, inhalation, swallowing, injection,
             246      or consumption, as distinguished from distribution, of controlled substances and includes
             247      individual, joint, or group possession or use of controlled substances. For a person to be a
             248      possessor or user of a controlled substance, it is not required that the person be shown to have
             249      individually possessed, used, or controlled the substance, but it is sufficient if it is shown that
             250      the person jointly participated with one or more persons in the use, possession, or control of
             251      any substances with knowledge that the activity was occurring, or the controlled substance is
             252      found in a place or under circumstances indicating that the person had the ability and the intent
             253      to exercise dominion and control over it.
             254          (jj) "Practitioner" means a physician, dentist, naturopathic physician, veterinarian,
             255      pharmacist, scientific investigator, pharmacy, hospital, or other person licensed, registered, or
             256      otherwise permitted to distribute, dispense, conduct research with respect to, administer, or use
             257      in teaching or chemical analysis a controlled substance in the course of professional practice or
             258      research in this state.
             259          (kk) "Prescribe" means to issue a prescription:
             260          (i) orally or in writing; or
             261          (ii) by telephone, facsimile transmission, computer, or other electronic means of
             262      communication as defined by division rule.
             263          (ll) "Prescription" means an order issued:
             264          (i) by a licensed practitioner, in the course of that practitioner's professional practice or
             265      by collaborative pharmacy practice agreement; and
             266          (ii) for a controlled substance or other prescription drug or device for use by a patient
             267      or an animal.
             268          (mm) "Production" means the manufacture, planting, cultivation, growing, or
             269      harvesting of a controlled substance.
             270          (nn) "Securities" means any stocks, bonds, notes, or other evidences of debt or of
             271      property.
             272          (oo) "State" means the state of Utah.
             273          (pp) "Ultimate user" means any person who lawfully possesses a controlled substance


             274      for the person's own use, for the use of a member of the person's household, or for
             275      administration to an animal owned by the person or a member of the person's household.
             276          (2) If a term used in this chapter is not defined, the definition and terms of Title 76,
             277      Utah Criminal Code, shall apply.
             278          Section 2. Section 58-37-4 is amended to read:
             279           58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
             280      required -- Specific substances included in schedules.
             281          (1) There are established five schedules of controlled substances known as Schedules I,
             282      II, III, IV, and V which consist of substances listed in this section.
             283          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
             284      the official name, common or usual name, chemical name, or brand name designated:
             285          (a) Schedule I:
             286          (i) Unless specifically excepted or unless listed in another schedule, any of the
             287      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             288      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             289      chemical designation:
             290          (A) Acetyl-alpha-methylfentanyl
             291      (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
             292          (B) Acetylmethadol;
             293          (C) Allylprodine;
             294          (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as
             295      levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
             296          (E) Alphameprodine;
             297          (F) Alphamethadol;
             298          (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
             299      propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
             300          (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
             301      piperidinyl]-N-phenylpropanamide);
             302          (I) Benzylpiperazine;
             303          [(I)] (J) Benzethidine;
             304          [(J)] (K) Betacetylmethadol;


             305          [(K)] (L) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
             306      piperidinyl]-N-phenylpropanamide);
             307          [(L)] (M) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
             308      phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
             309          [(M)] (N) Betameprodine;
             310          [(N)] (O) Betamethadol;
             311          [(O)] (P) Betaprodine;
             312          [(P)] (Q) Clonitazene;
             313          [(Q)] (R) Dextromoramide;
             314          [(R)] (S) Diampromide;
             315          [(S)] (T) Diethylthiambutene;
             316          [(T)] (U) Difenoxin;
             317          [(U)] (V) Dimenoxadol;
             318          [(V)] (W) Dimepheptanol;
             319          [(W)] (X) Dimethylthiambutene;
             320          [(X)] (Y) Dioxaphetyl butyrate;
             321          [(Y)] (Z) Dipipanone;
             322          [(Z)] (AA) Ethylmethylthiambutene;
             323          [(AA)] (BB) Etonitazene;
             324          [(BB)] (CC) Etoxeridine;
             325          [(CC)] (DD) Furethidine;
             326          [(DD)] (EE) Hydroxypethidine;
             327          [(EE)] (FF) Ketobemidone;
             328          [(FF)] (GG) Levomoramide;
             329          [(GG)] (HH) Levophenacylmorphan;
             330          [(HH)] (II) Morpheridine;
             331          [(II)] (JJ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
             332          [(JJ)] (KK) Noracymethadol;
             333          [(KK)] (LL) Norlevorphanol;
             334          [(LL)] (MM) Normethadone;
             335          [(MM)] (NN) Norpipanone;


             336          [(NN)] (OO) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
             337      piperidinyl] propanamide;
             338          [(OO)] (PP) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
             339          [(PP)] (QQ) Phenadoxone;
             340          [(QQ)] (RR) Phenampromide;
             341          [(RR)] (SS) Phenomorphan;
             342          [(SS)] (TT) Phenoperidine;
             343          [(TT)] (UU) Piritramide;
             344          [(UU)] (VV) Proheptazine;
             345          [(VV)] (WW) Properidine;
             346          [(WW)] (XX) Propiram;
             347          [(XX)] (YY) Racemoramide;
             348          [(YY)] (ZZ) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
             349      propanamide;
             350          [(ZZ)] (AAA) Tilidine;
             351          [(AAA)] (BBB) Trimeperidine;
             352          [(BBB)] (CCC) 3-methylfentanyl, including the optical and geometric isomers
             353      (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
             354          [(CCC)] (DDD) 3-methylthiofentanyl
             355      (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
             356          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             357      following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
             358      salts, isomers, and salts of isomers is possible within the specific chemical designation:
             359          (A) Acetorphine;
             360          (B) Acetyldihydrocodeine;
             361          (C) Benzylmorphine;
             362          (D) Codeine methylbromide;
             363          (E) Codeine-N-Oxide;
             364          (F) Cyprenorphine;
             365          (G) Desomorphine;
             366          (H) Dihydromorphine;


             367          (I) Drotebanol;
             368          (J) Etorphine (except hydrochloride salt);
             369          (K) Heroin;
             370          (L) Hydromorphinol;
             371          (M) Methyldesorphine;
             372          (N) Methylhydromorphine;
             373          (O) Morphine methylbromide;
             374          (P) Morphine methylsulfonate;
             375          (Q) Morphine-N-Oxide;
             376          (R) Myrophine;
             377          (S) Nicocodeine;
             378          (T) Nicomorphine;
             379          (U) Normorphine;
             380          (V) Pholcodine; and
             381          (W) Thebacon.
             382          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             383      compound, mixture, or preparation which contains any quantity of the following hallucinogenic
             384      substances, or which contains any of their salts, isomers, and salts of isomers when the
             385      existence of the salts, isomers, and salts of isomers is possible within the specific chemical
             386      designation; as used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and
             387      geometric isomers:
             388          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
             389      .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
             390          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
             391      4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
             392          (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
             393      2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
             394          (D) 2,5-dimethoxyamphetamine, some trade or other names:
             395      2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
             396          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
             397          (F) 4-methoxyamphetamine, some trade or other names:


             398      4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
             399          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
             400          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
             401      4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
             402          (I) 3,4-methylenedioxy amphetamine;
             403          (J) 3,4-methylenedioxymethamphetamine (MDMA);
             404          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
             405      alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
             406          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
             407      N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
             408          (M) 3,4,5-trimethoxy amphetamine;
             409          (N) Bufotenine, some trade and other names:
             410      3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
             411      N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
             412          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
             413          (P) Dimethyltryptamine, some trade or other names: DMT;
             414          (Q) Ibogaine, some trade and other names:
             415      7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
             416      [5,4-b] indole; Tabernanthe iboga;
             417          (R) Lysergic acid diethylamide;
             418          (S) Marijuana;
             419          (T) Mescaline;
             420          (U) Parahexyl, some trade or other names:
             421      3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
             422          (V) Peyote, meaning all parts of the plant presently classified botanically as
             423      Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
             424      any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
             425      preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
             426          (W) N-ethyl-3-piperidyl benzilate;
             427          (X) N-methyl-3-piperidyl benzilate;
             428          (Y) Psilocybin;


             429          (Z) Psilocyn;
             430          (AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
             431      (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis
             432      plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
             433      and their isomers with similar chemical structure and pharmacological activity to those
             434      substances contained in the plant, such as the following: .1 cis or trans tetrahydrocannabinol,
             435      and their optical isomers .6 cis or trans tetrahydrocannabinol, and their optical isomers .3,4
             436      cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
             437      substances is not internationally standardized, compounds of these structures, regardless of
             438      numerical designation of atomic positions covered;
             439          (BB) Ethylamine analog of phencyclidine, some trade or other names:
             440      N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
             441      N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
             442          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
             443      1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
             444          (DD) Thiophene analog of phencyclidine, some trade or other names:
             445      1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
             446          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
             447          (iv) Unless specifically excepted or unless listed in another schedule, any material
             448      compound, mixture, or preparation which contains any quantity of the following substances
             449      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             450      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             451      specific chemical designation:
             452          (A) Mecloqualone; and
             453          (B) Methaqualone.
             454          (v) Any material, compound, mixture, or preparation containing any quantity of the
             455      following substances having a stimulant effect on the central nervous system, including their
             456      salts, isomers, and salts of isomers:
             457          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
             458      4,5-dihydro-5-phenyl-2-oxazolamine;
             459          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,


             460      alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
             461          (C) Fenethylline;
             462          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
             463      alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
             464      alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
             465      methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
             466      optical isomers;
             467          (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
             468          (F) N-ethylamphetamine; and
             469          (G) N,N-dimethylamphetamine, also known as
             470      N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
             471          (vi) Any material, compound, mixture, or preparation which contains any quantity of
             472      the following substances, including their optical isomers, salts, and salts of isomers, subject to
             473      temporary emergency scheduling:
             474          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
             475          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
             476          (vii) Unless specifically excepted or unless listed in another schedule, any material,
             477      compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
             478      (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
             479          (b) Schedule II:
             480          (i) Unless specifically excepted or unless listed in another schedule, any of the
             481      following substances whether produced directly or indirectly by extraction from substances of
             482      vegetable origin, or independently by means of chemical synthesis, or by a combination of
             483      extraction and chemical synthesis:
             484          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
             485      opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
             486      and their respective salts, but including:
             487          (I) Raw opium;
             488          (II) Opium extracts;
             489          (III) Opium fluid;
             490          (IV) Powdered opium;


             491          (V) Granulated opium;
             492          (VI) Tincture of opium;
             493          (VII) Codeine;
             494          (VIII) Ethylmorphine;
             495          (IX) Etorphine hydrochloride;
             496          (X) Hydrocodone;
             497          (XI) Hydromorphone;
             498          (XII) Metopon;
             499          (XIII) Morphine;
             500          (XIV) Oxycodone;
             501          (XV) Oxymorphone; and
             502          (XVI) Thebaine;
             503          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
             504      identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
             505      substances may not include the isoquinoline alkaloids of opium;
             506          (C) Opium poppy and poppy straw;
             507          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
             508      any salt, compound, derivative, or preparation which is chemically equivalent or identical with
             509      any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
             510      and salts of isomers and derivatives, whether derived from the coca plant or synthetically
             511      produced, except the substances may not include decocainized coca leaves or extraction of coca
             512      leaves, which extractions do not contain cocaine or ecgonine; and
             513          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
             514      liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
             515          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             516      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             517      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             518      chemical designation, except dextrorphan and levopropoxyphene:
             519          (A) Alfentanil;
             520          (B) Alphaprodine;
             521          (C) Anileridine;


             522          (D) Bezitramide;
             523          (E) Bulk dextropropoxyphene (nondosage forms);
             524          (F) Carfentanil;
             525          (G) Dihydrocodeine;
             526          (H) Diphenoxylate;
             527          (I) Fentanyl;
             528          (J) Isomethadone;
             529          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
             530      levomethadyl acetate, or LAAM;
             531          (L) Levomethorphan;
             532          (M) Levorphanol;
             533          (N) Metazocine;
             534          (O) Methadone;
             535          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
             536          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
             537      acid;
             538          (R) Pethidine (meperidine);
             539          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
             540          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
             541          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
             542          (V) Phenazocine;
             543          (W) Piminodine;
             544          (X) Racemethorphan;
             545          (Y) Racemorphan;
             546          (Z) Remifentanil; and
             547          (AA) Sufentanil.
             548          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             549      compound, mixture, or preparation which contains any quantity of the following substances
             550      having a stimulant effect on the central nervous system:
             551          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
             552          (B) Methamphetamine, its salts, isomers, and salts of its isomers;


             553          (C) Phenmetrazine and its salts; and
             554          (D) Methylphenidate.
             555          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             556      compound, mixture, or preparation which contains any quantity of the following substances
             557      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             558      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             559      specific chemical designation:
             560          (A) Amobarbital;
             561          (B) Glutethimide;
             562          (C) Pentobarbital;
             563          (D) Phencyclidine;
             564          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
             565      1-piperidinocyclohexanecarbonitrile (PCC); and
             566          (F) Secobarbital.
             567          (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
             568      compound, mixture, or preparation which contains any quantity of Phenylacetone.
             569          (B) Some of these substances may be known by trade or other names:
             570      phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
             571          (vi) Nabilone, another name for nabilone:
             572      (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
             573      6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
             574          (c) Schedule III:
             575          (i) Unless specifically excepted or unless listed in another schedule, any material,
             576      compound, mixture, or preparation which contains any quantity of the following substances
             577      having a stimulant effect on the central nervous system, including its salts, isomers whether
             578      optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
             579      and salts of isomers is possible within the specific chemical designation:
             580          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
             581      stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
             582      listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
             583      Code of Federal Regulations, and any other drug of the quantitive composition shown in that


             584      list for those drugs or which is the same except that it contains a lesser quantity of controlled
             585      substances;
             586          (B) Benzphetamine;
             587          (C) Chlorphentermine;
             588          (D) Clortermine; and
             589          (E) Phendimetrazine.
             590          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             591      compound, mixture, or preparation which contains any quantity of the following substances
             592      having a depressant effect on the central nervous system:
             593          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
             594      pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
             595      which are not listed in any schedule;
             596          (B) Any suppository dosage form containing amobarbital, secobarbital, or
             597      pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
             598      Administration for marketing only as a suppository;
             599          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
             600      salt of any of them;
             601          (D) Chlorhexadol;
             602          (E) Buprenorphine;
             603          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
             604      isomers, and salts of isomers, for which an application is approved under the federal Food,
             605      Drug, and Cosmetic Act, Section 505;
             606          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
             607      . -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
             608          (H) Lysergic acid;
             609          (I) Lysergic acid amide;
             610          (J) Methyprylon;
             611          (K) Sulfondiethylmethane;
             612          (L) Sulfonethylmethane;
             613          (M) Sulfonmethane; and
             614          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a


             615      tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
             616      2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
             617      4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
             618      flupyrazapon.
             619          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
             620      U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
             621      (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
             622      (-)-delta-9-(trans)-tetrahydrocannabinol.
             623          (iv) Nalorphine.
             624          (v) Unless specifically excepted or unless listed in another schedule, any material,
             625      compound, mixture, or preparation containing limited quantities of any of the following
             626      narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
             627          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             628      milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
             629      opium;
             630          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             631      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             632      therapeutic amounts;
             633          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             634      than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
             635      alkaloid of opium;
             636          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             637      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             638      recognized therapeutic amounts;
             639          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
             640      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             641      therapeutic amounts;
             642          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
             643      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             644      recognized therapeutic amounts;
             645          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not


             646      more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             647      recognized therapeutic amounts; and
             648          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
             649      one or more active, non-narcotic ingredients in recognized therapeutic amounts.
             650          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
             651      including any of the following or any isomer, ester, salt, or derivative of the following that
             652      promotes muscle growth:
             653          (A) Boldenone;
             654          (B) Chlorotestosterone (4-chlortestosterone);
             655          (C) Clostebol;
             656          (D) Dehydrochlormethyltestosterone;
             657          (E) Dihydrotestosterone (4-dihydrotestosterone);
             658          (F) Drostanolone;
             659          (G) Ethylestrenol;
             660          (H) Fluoxymesterone;
             661          (I) Formebulone (formebolone);
             662          (J) Mesterolone;
             663          (K) Methandienone;
             664          (L) Methandranone;
             665          (M) Methandriol;
             666          (N) Methandrostenolone;
             667          (O) Methenolone;
             668          (P) Methyltestosterone;
             669          (Q) Mibolerone;
             670          (R) Nandrolone;
             671          (S) Norethandrolone;
             672          (T) Oxandrolone;
             673          (U) Oxymesterone;
             674          (V) Oxymetholone;
             675          (W) Stanolone;
             676          (X) Stanozolol;


             677          (Y) Testolactone;
             678          (Z) Testosterone; and
             679          (AA) Trenbolone.
             680          (vii) Anabolic steroids expressly intended for administration through implants to cattle
             681      or other nonhuman species, and approved by the Secretary of Health and Human Services for
             682      use, may not be classified as a controlled substance.
             683          (d) Schedule IV:
             684          (i) Unless specifically excepted or unless listed in another schedule, any material,
             685      compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
             686      less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
             687          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             688      compound, mixture, or preparation which contains any quantity of the following substances,
             689      including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
             690      salts of isomers is possible within the specific chemical designation:
             691          (A) Alprazolam;
             692          (B) Barbital;
             693          (C) Bromazepam;
             694          (D) Butorphanol;
             695          (E) Camazepam;
             696          (F) Carisoprodol;
             697          (G) Chloral betaine;
             698          (H) Chloral hydrate;
             699          (I) Chlordiazepoxide;
             700          (J) Clobazam;
             701          (K) Clonazepam;
             702          (L) Clorazepate;
             703          (M) Clotiazepam;
             704          (N) Cloxazolam;
             705          (O) Delorazepam;
             706          (P) Diazepam;
             707          (Q) Dichloralphenazone;


             708          (R) Estazolam;
             709          (S) Ethchlorvynol;
             710          (T) Ethinamate;
             711          (U) Ethyl loflazepate;
             712          (V) Fludiazepam;
             713          (W) Flunitrazepam;
             714          (X) Flurazepam;
             715          (Y) Halazepam;
             716          (Z) Haloxazolam;
             717          (AA) Ketazolam;
             718          (BB) Loprazolam;
             719          (CC) Lorazepam;
             720          (DD) Lormetazepam;
             721          (EE) Mebutamate;
             722          (FF) Medazepam;
             723          (GG) Meprobamate;
             724          (HH) Methohexital;
             725          (II) Methylphenobarbital (mephobarbital);
             726          (JJ) Midazolam;
             727          (KK) Nimetazepam;
             728          (LL) Nitrazepam;
             729          (MM) Nordiazepam;
             730          (NN) Oxazepam;
             731          (OO) Oxazolam;
             732          (PP) Paraldehyde;
             733          (QQ) Pentazocine;
             734          (RR) Petrichloral;
             735          (SS) Phenobarbital;
             736          (TT) Pinazepam;
             737          (UU) Prazepam;
             738          (VV) Quazepam;


             739          (WW) Temazepam;
             740          (XX) Tetrazepam;
             741          (YY) Triazolam;
             742          (ZZ) Zaleplon; and
             743          (AAA) Zolpidem.
             744          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
             745      any quantity of the following substances, including its salts, isomers whether optical, position,
             746      or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
             747      isomers is possible.
             748          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             749      compound, mixture, or preparation which contains any quantity of the following substances
             750      having a stimulant effect on the central nervous system, including its salts, isomers whether
             751      optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
             752      isomers, and salts of isomers is possible within the specific chemical designation:
             753          (A) Cathine ((+)-norpseudoephedrine);
             754          (B) Diethylpropion;
             755          (C) Fencamfamine;
             756          (D) Fenproprex;
             757          (E) Mazindol;
             758          (F) Mefenorex;
             759          (G) Modafinil;
             760          (H) Pemoline, including organometallic complexes and chelates thereof;
             761          (I) Phentermine;
             762          (J) Pipradrol;
             763          (K) Sibutramine; and
             764          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
             765          (v) Unless specifically excepted or unless listed in another schedule, any material,
             766      compound, mixture, or preparation which contains any quantity of dextropropoxyphene
             767      (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
             768          (e) Schedule V: Any compound, mixture, or preparation containing any of the
             769      following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous


             770      base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
             771      sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
             772      qualities other than those possessed by the narcotic drug alone:
             773          (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
             774          (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
             775      grams;
             776          (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
             777      grams;
             778          (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
             779      atropine sulfate per dosage unit;
             780          (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
             781          (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
             782      atropine sulfate per dosage unit; and
             783          (vii) unless specifically exempted or excluded or unless listed in another schedule, any
             784      material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
             785      effect on the central nervous system, including its salts, isomers, and salts of isomers.
             786          Section 3. Section 58-37-4.2 is amended to read:
             787           58-37-4.2. Listed controlled substances.
             788          The following substances, their analogs, homologs, and synthetic equivalents are listed
             789      controlled substances:
             790          (1) AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;
             791          (2) AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;
             792          [(2)] (3) CP 47,497 and its C6, C8, and C9 homologs;
             793      2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol;
             794          (4) Fluoromethcathinone;
             795          [(3)] (5) HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
             796      -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
             797          [(4)] (6) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
             798      methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
             799          [(5)] (7) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
             800          [(6)] (8) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as


             801      1-Pentyl-3-(1-naphthoyl)indole};
             802          [(7)] (9) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;
             803          [(8)] (10) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
             804      1-Butyl-3-(1-naphthoyl)indole};
             805          [(9)] (11) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
             806          [(10)] (12) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
             807          [(11)] (13) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;
             808          (14) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
             809          (15) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
             810          [(12)] (16) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
             811          [(13)] (17) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
             812          [(14)] (18) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;
             813          (19) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
             814          [(15)] (20) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
             815      known as BTW-8 and SR-18};
             816          [(16)] (21) 4-methylmethcathinone {also known as mephedrone};
             817          [(17)] (22) 3,4-methylenedioxypyrovalerone {also known as MDPV};
             818          [(18)] (23) 3,4-Methylenedioxymethcathinone {also known as methylone}; and
             819          [(19)] (24) 4-methoxymethcathinone[;].
             820          [(20) 4-Fluoromethcathinone; and]
             821          [(21) 3-Fluoromethcathinone.]


[Bill Documents][Bills Directory]